- Home
- IOR vs NTRB Comparison
IOR vs NTRB Comparison
Compare IOR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOR
- NTRB
- Stock Information
- Founded
- IOR 1984
- NTRB 2016
- Country
- IOR United States
- NTRB United States
- Employees
- IOR N/A
- NTRB N/A
- Industry
- IOR Real Estate Investment Trusts
- NTRB Industrial Specialties
- Sector
- IOR Real Estate
- NTRB Health Care
- Exchange
- IOR Nasdaq
- NTRB Nasdaq
- Market Cap
- IOR 68.6M
- NTRB 77.9M
- IPO Year
- IOR N/A
- NTRB N/A
- Fundamental
- Price
- IOR $16.87
- NTRB $4.73
- Analyst Decision
- IOR
- NTRB
- Analyst Count
- IOR 0
- NTRB 0
- Target Price
- IOR N/A
- NTRB N/A
- AVG Volume (30 Days)
- IOR 1.2K
- NTRB 19.7K
- Earning Date
- IOR 11-07-2024
- NTRB 12-11-2024
- Dividend Yield
- IOR N/A
- NTRB N/A
- EPS Growth
- IOR 5.45
- NTRB N/A
- EPS
- IOR 1.47
- NTRB N/A
- Revenue
- IOR N/A
- NTRB $1,803,816.00
- Revenue This Year
- IOR N/A
- NTRB N/A
- Revenue Next Year
- IOR N/A
- NTRB N/A
- P/E Ratio
- IOR $11.42
- NTRB N/A
- Revenue Growth
- IOR N/A
- NTRB N/A
- 52 Week Low
- IOR $11.66
- NTRB $2.09
- 52 Week High
- IOR $19.00
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- IOR 46.07
- NTRB 35.87
- Support Level
- IOR $16.50
- NTRB $4.68
- Resistance Level
- IOR $17.14
- NTRB $5.33
- Average True Range (ATR)
- IOR 0.13
- NTRB 0.44
- MACD
- IOR 0.01
- NTRB -0.15
- Stochastic Oscillator
- IOR 35.21
- NTRB 10.17
About IOR Income Opportunity Realty Investors Inc.
Income Opportunity Realty Investors Inc is a U.S.-based company that is an externally managed company that invests in mortgage notes receivables and real property. Its business is managed by Pillar Income Asset Management, Inc. Pillar's duties include, but are not limited to, locating, evaluating and recommending real estate and real estate-related investment opportunities. Pillar also arranges its debt and equity financing with unaffiliated independent third party lenders and investors.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.